Lumigo Dry Syrup

Lumigo Dry Syrup belongs to the class of 'anti-malarial drugs', primarily used to treat and prevent malaria. Malaria is a disease caused by a plasmodium parasite, transmitted by the bite of infected Anopheles mosquitoes. When an infected mosquito bites a healthy person, it transmits the 'Plasmodium parasite' into the bloodstream, which affects the red blood cells and liver cells. Malaria symptoms usually start in 10 days to 4 weeks after the infection. They include chills, high fever, profuse sweating, headache, nausea, vomiting, abdominal pain, diarrhoea, anaemia, muscle pain, convulsions, coma and bloody stools.

Lumigo Dry Syrup contains two medicines, namely: Artemether and Lumefantrine. These are anti-malarial drugs that interfere with Plasmodium parasite's growth in the red blood cells of the human body. Lumigo Dry Syrup is a combination that is used to treat non-severe malaria caused by a parasite called 'Plasmodium falciparum,' other Plasmodium species. It works by inhibiting nucleic acid and protein synthesis in Plasmodium falciparum. Artemether is known to reduce parasite biomass and Lumefantrine eliminates residual parasites.

Your doctor will decide the dose and duration based on your medical condition. Common side effects of Lumigo Dry Syrup include headache, dizziness, loss of appetite, weakness, fever, chills, tiredness, muscle/joint pain, nausea, vomiting, abdominal pain, cough and trouble sleeping. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.

Before using Lumigo Dry Syrup, inform your doctor if you recently used any prescription and non-prescription medications, including other anti-malarial or antibiotic drugs. Let your doctor know if you are allergic to Lumigo Dry Syrup or its components. Inform your doctor if you have any liver or kidney problems, severe heart diseases and electrolyte imbalance. It is essential to let your doctor know if you are pregnant, planning to conceive or a breastfeeding mother. Avoiding alcohol is recommended to rule out any possibility of side effects.

Lumigo Dry Syrup contains two anti-malarial drugs, namely: Artemether and Lumefantrine. It is a combination that treats non-severe malaria caused by a parasite called 'Plasmodium falciparum', other Plasmodium species. It interferes with the growth of Plasmodium parasites in the red blood cells of the human body. Lumigo Dry Syrup works by inhibiting nucleic acid and protein synthesis in Plasmodium falciparum. Artemether reduces parasite biomass and Lumefantrine eliminates residual parasites.

Let your doctor know if you use any antibiotic drugs or have recently undergone treatment with other anti-malarial drugs. Brief your medical history to the doctor if you have any liver or kidney problems, malarial infection of the brain, lungs or kidneys, severe heart diseases and electrolyte imbalance. It is essential to inform your doctor if you have hypokalemia (low potassium levels) or hypomagnesemia (low magnesium levels) before starting Lumigo Dry Syrup. Lumigo Dry Syrup may affect QT prolongation that can cause serious fast/irregular heartbeat. Hence it is advised to inform your doctor if you have any heart-related problems like heart failure, slow heartbeat, QT prolongation in EKG or ECG (electrocardiogram), and a family history of heart diseases. It is essential to let your doctor know if you are pregnant, planning to conceive or a breastfeeding mother before starting Lumigo Dry Syrup. Avoiding alcohol is recommended to rule out any possibility of side effects like dizziness or drowsiness.

• Let your doctor know that you are taking Lumigo Dry Syrup if you are undergoing any medical tests.
• Regular monitoring of heart function with ECG or EKG is necessary.
• Liver and kidney function tests are recommended to rule out any chances of kidney or liver impairment.
• Lumigo Dry Syrup may decrease the effectiveness of hormonal birth control such as pills, patch, or ring. This could cause pregnancy.